Published in Rheumatology (Oxford) on September 01, 2001
Applications of nanotechnology for immunology. Nat Rev Immunol (2013) 1.65
Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis (2004) 1.09
Targeted liposomal drug delivery to monocytes and macrophages. J Drug Deliv (2010) 1.08
Development of macromolecular prodrug for rheumatoid arthritis. Adv Drug Deliv Rev (2012) 1.07
Innate immunity and rheumatoid arthritis. Rheum Dis Clin North Am (2010) 1.06
Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. J R Soc Interface (2009) 0.99
Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy? Arthritis Res Ther (2009) 0.88
Anti-arthritis activity of cationic materials. J Cell Mol Med (2009) 0.76
Application of liposomes in treatment of rheumatoid arthritis: quo vadis. ScientificWorldJournal (2014) 0.75
Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol (1978) 3.06
Increased rates of muscle protein turnover and amino acid transport after resistance exercise in humans. Am J Physiol (1995) 2.78
Iliopsoas bursitis-an unusual presentation of metastatic bone disease. Br J Rheumatol (1996) 2.32
Assembly of body wall muscle and muscle cell attachment structures in Caenorhabditis elegans. J Cell Biol (1994) 2.26
Products of the unc-52 gene in Caenorhabditis elegans are homologous to the core protein of the mammalian basement membrane heparan sulfate proteoglycan. Genes Dev (1993) 2.15
Defective reticuloendothelial system function in rheumatoid arthritis. Lancet (1979) 2.10
The UNC-112 gene in Caenorhabditis elegans encodes a novel component of cell-matrix adhesion structures required for integrin localization in the muscle cell membrane. J Cell Biol (2000) 2.06
Internalization of Staphylococcus aureus by cultured osteoblasts. Microb Pathog (1995) 2.03
Minocycline-related lupus. Br J Rheumatol (1994) 1.96
Immune complexes in Behçet's syndrome and recurrent oral ulceration. Br Med J (1977) 1.88
Molecular cloning and expression of flagellar radial spoke and dynein genes of Chlamydomonas. J Cell Biol (1986) 1.83
Behçet's syndrome: severe proctitis with rectovaginal fistula formation. Ann Rheum Dis (1989) 1.61
Rescue of a paralyzed-flagella mutant of Chlamydomonas by transformation. Proc Natl Acad Sci U S A (1990) 1.60
Point mutations in the stem-loop at the 3' end of mouse histone mRNA reduce expression by reducing the efficiency of 3' end formation. Mol Cell Biol (1994) 1.53
Circulating immune complexes and symptoms in Hodgkin's disease. Lancet (1976) 1.53
Idiopathic recurrent non-suppurative focal myositis: a report of two cases. Br J Rheumatol (1993) 1.49
Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C. Am J Ophthalmol (1997) 1.48
Glucose kinetics during high-intensity exercise in endurance-trained and untrained humans. J Appl Physiol (1985) (1995) 1.48
Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise. Diabetes (1999) 1.44
A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population. Am J Ophthalmol (1993) 1.38
Sequence analysis reveals homology between two proteins of the flagellar radial spoke. Mol Cell Biol (1992) 1.32
Clinical experience with the Baerveldt glaucoma drainage implant. Ophthalmology (1995) 1.25
Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Clin Exp Immunol (1976) 1.22
Measurement of terminal complement complexes in rheumatoid arthritis. Clin Exp Immunol (1988) 1.20
Cushing's syndrome with suppression of the hypothalamic-pituitary-adrenal axis after intra-articular steroid injections. Ann Rheum Dis (1985) 1.12
Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack. Immunology (1990) 1.12
Correlation between immune complexes and prognostic factors in Hodgkin's disease. Clin Exp Immunol (1978) 1.11
Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis. Rheumatology (Oxford) (1999) 1.06
Muscle protein metabolism in female swimmers after a combination of resistance and endurance exercise. J Appl Physiol (1985) (1996) 1.06
Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. Br Med J (Clin Res Ed) (1984) 1.06
AIDS presenting as acute glaucoma. Case report. Arch Ophthalmol (1988) 1.05
Detection of immune complexes in serum of patients with ankylosing spondylitis. Ann Rheum Dis (1978) 1.05
Genomic organization, expression, and analysis of the troponin C gene pat-10 of Caenorhabditis elegans. J Cell Biol (1999) 1.02
In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium. Clin Exp Immunol (1988) 1.02
Letter: Precipitating antibodies in systemic lupus. Lancet (1974) 1.01
Calcium pyrophosphate deposition disease--involvement of the acromioclavicular joint with pseudocyst formation. Br J Rheumatol (1993) 1.00
Evaluation of antenatal and postnatal support to overcome postnatal depression: a randomized, controlled trial. Birth (1995) 0.99
Synovial accumulation of technetium labelled liposomes in rheumatoid arthritis. Ann Rheum Dis (1987) 0.98
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group. J Rheumatol (2001) 0.98
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesterase. J Med Chem (1998) 0.98
Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo. Clin Exp Immunol (2002) 0.97
Therapeutic efficacy of a novel membrane-targeted complement regulator in antigen-induced arthritis in the rat. Arthritis Rheum (2000) 0.97
Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis. Br J Rheumatol (1994) 0.96
Tumour necrosis factor activity in joint fluids from rheumatoid arthritis patients. Br J Rheumatol (1989) 0.95
Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes. Clin Exp Immunol (1982) 0.94
Studies in the rat of antibody-coated and N-ethylmaleimide-treated erythrocyte clearance by the spleen. I. Effects of in vivo complement activation. Immunology (1986) 0.94
Synthesis and characterization of 5-[(4-Azidophenacyl)thio]uridine 5'-triphosphate, a cleavable photo-cross-linking nucleotide analogue. Biochemistry (1989) 0.94
Minocycline-induced lupus: clinical features and response to rechallenge. Rheumatology (Oxford) (2001) 0.93
Local therapy with soluble complement receptor 1 (sCR1) suppresses inflammation in rat mono-articular arthritis. Clin Exp Immunol (1997) 0.93
Small-intestinal perforation secondary to localized giant-cell arteritis of the mesenteric vessels. Br J Rheumatol (1988) 0.92
Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. Br J Rheumatol (1993) 0.92
The isolation and characterization of a novel G protein-coupled receptor regulated by immunologic challenge. Brain Res (1997) 0.91
Antibodies to protein P in systemic lupus erythematosus. Ann Rheum Dis (1992) 0.90
Inflammatory joint disease: a comparison of liposome scanning, bone scanning, and radiography. Ann Rheum Dis (1988) 0.90
Studies in the rat of antibody-sensitized and N-ethylmaleimide-treated erythrocyte clearance by the liver: effects of immune complex infusion and complement activation. Immunology (1988) 0.89
Amelioration of rat antigen-induced arthritis by liposomally conjugated methotrexate is accompanied by down-regulation of cytokine mRNA expression. Rheumatology (Oxford) (2001) 0.89
A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis. Br J Rheumatol (1996) 0.88
Predicting postnatal depression among pregnant women. Birth (1996) 0.88
The penetration of ceftriaxone into synovial fluid of the inflamed joint. J Antimicrob Chemother (1985) 0.87
Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis. Rheumatology (Oxford) (2007) 0.87
Circulating immune complexes in patients with ankylosing spondylitis. Ann Rheum Dis (1980) 0.87
Studies in cobra venom factor treated rats of antibody coated erythrocyte clearance by the spleen: differential influence of red blood cell antigen number on the inhibitory effects of immune complexes on Fc dependent clearance. Clin Exp Immunol (1986) 0.87
Role of Rho kinase isoforms in murine allergic airway responses. Eur Respir J (2011) 0.87
The effect of liposomally conjugated methotrexate upon mediator release from human peripheral blood monocytes. Br J Rheumatol (1995) 0.86
Systemic lupus erythematosus presenting as pneumococcal septicaemia and septic arthritis. Ann Rheum Dis (1990) 0.86
Imaging in rheumatoid arthritis using liposomes labelled with technetium. Br Med J (Clin Res Ed) (1986) 0.86
Reticuloendothelial Fc receptor function in patients with Sjogren's syndrome. Clin Exp Immunol (1985) 0.85
Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9. Br J Pharmacol (2012) 0.85
Oral branched-chain amino acids decrease whole-body proteolysis. JPEN J Parenter Enteral Nutr (1995) 0.85
Permanent genetic resources added to Molecular Ecology Resources Database 1 August 2010-30 September 2010. Mol Ecol Resour (2011) 0.85
Diabetes information for the visually impaired. Diabetes Self Manag (2007) 0.85
Immune complexes in Hodgkin's disease: isolation, immunochemical and physico-chemical analysis. Clin Exp Immunol (1983) 0.85
Serious opportunistic infection associated with gold-induced panhypogammaglobulinaemia. Br J Rheumatol (1998) 0.84
Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis. Ann Rheum Dis (1990) 0.84
Algal degradation of a known endocrine disrupting insecticide, alpha-endosulfan, and its metabolite, endosulfan sulfate, in liquid medium and soil. J Agric Food Chem (2004) 0.84
Studies in the rat of antibody-coated and N-ethylmaleimide-treated erythrocyte clearance by the spleen. II. Effects of immune complex infusion. Immunology (1986) 0.84
Single cell imaging reveals abnormal intracellular calcium signals within rheumatoid synovial neutrophils. Br J Rheumatol (1991) 0.83
Reticuloendothelial Fc function in normal individuals and its relationship to the HLA antigen DR3. Clin Exp Immunol (1985) 0.83
Specific accumulation of technetium-99m radiolabelled, negative liposomes in the inflamed paws of rats with adjuvant induced arthritis: effect of liposome size. Ann Rheum Dis (1989) 0.83
Population Behavior of Meloidogyne graminis in Field-grown 'Tifgreen' Bermudagrass. J Nematol (1971) 0.83
The effect of free and liposome-encapsulated clodronate on the hepatic mononuclear phagocyte system in the rat. Clin Exp Immunol (1995) 0.83
Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A. Ann Rheum Dis (2013) 0.83
Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis. Clin Exp Immunol (2000) 0.83
Suppression of adjuvant-induced arthritis by liposomally conjugated methotrexate in the rat. Br J Rheumatol (1994) 0.82
Hybridization of bean leaf leucyl-tRNA with nuclear DNA and with chloroplast DNA. Biochem Biophys Res Commun (1970) 0.82
Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions. Clin Exp Immunol (1991) 0.82
Intracellular measurement of prostaglandin E2: effect of anti-inflammatory drugs on cyclooxygenase activity and prostanoid expression. Anal Biochem (1999) 0.82
Lymphoproliferation in primary Sjögren's syndrome. Evidence of selective expansion of a B cell subset characterized by the expression of cross-reactive idiotypes. Arthritis Rheum (1993) 0.82
Identification and gene expression of anaerobically induced enolase in Echinochloa phyllopogon and Echinochloa crus-pavonis. Plant Physiol (1995) 0.82
Vitamin E content of feedstuffs determined by high-performance liquid chromatographic fluorescence. J Agric Food Chem (1984) 0.81
Circulating immune complexes after repeated halothane anaesthesia. Br Med J (1977) 0.81
Hybridization of leucyl-transfer ribonucleic Acid isoacceptors from green leaves with nuclear and chloroplast deoxyribonucleic Acid. Proc Natl Acad Sci U S A (1973) 0.81
A simple and sensitive micro-haemagglutination inhibition assay for the semi-quantitation of the third component of complement. J Immunol Methods (1975) 0.81
Histologic study of healing after ab interno laser sclerostomy. Am J Ophthalmol (1992) 0.81
Classical pathway activation of complement system by IgA anti-C3 antibody. Nature (1976) 0.81